tiprankstipranks
Trending News
More News >
Santen Pharmaceutical Co (JP:4536)
:4536

Santen Pharmaceutical Co (4536) Revenue

Compare
0 Followers

Santen Pharmaceutical Co Revenue

Santen Pharmaceutical Co had a revenue of 77.23B in the quarter ending Mar 31, 2025, with 1.13%. This bring the company's revenue in the last twelve months to 300.00B, Increased -0.63%. In the fiscal year ending Mar 31, 2025, Santen Pharmaceutical Co had annual revenue of 300.00B with -0.65% growth.
Revenue (ttm)
300.00B
Revenue Growth
-0.06%
P/S Ratio
1.90
Revenue/Employee
¥80,129,274
Employees
3,744
Market Cap
¥571.38B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2025
300.00B-1.96B-0.65%
Mar 31, 2024
301.96B22.93B+8.22%
Mar 31, 2023
279.04B12.78B+4.80%
Mar 31, 2022
266.26B16.65B+6.67%
Mar 31, 2021
249.60B8.05B+3.33%
Mar 31, 2020
241.56B7.53B+3.22%
Mar 31, 2019
234.03B9.08B+4.04%
Mar 31, 2018
224.94B25.85B+12.98%
Mar 31, 2017
199.10B
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis